Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol.
Saved in:
| Title: | Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol. |
|---|---|
| Authors: | Toh, Tan Boon1,2 (AUTHOR) lsittb@nus.edu.sg, Thng, Dexter Kai Hao1,3 (AUTHOR), Bolem, Nagarjun4 (AUTHOR), Vellayappan, Balamurugan A.5 (AUTHOR), Tan, Bryce Wei Quan3 (AUTHOR), Shen, Yating1,3 (AUTHOR), Soon, Sou Yen6 (AUTHOR), Ang, Yvonne Li En6 (AUTHOR), Dinesh, Nivedh4 (AUTHOR), Teo, Kejia4 (AUTHOR), Nga, Vincent Diong Weng4 (AUTHOR), Low, Shiong Wen7 (AUTHOR), Khong, Pek Lan8,9 (AUTHOR), Chow, Edward Kai-Hua1,2,3 (AUTHOR), Ho, Dean1,2 (AUTHOR), Yeo, Tseng Tsai4 (AUTHOR), Wong, Andrea Li Ann3,6 (AUTHOR) lsittb@nus.edu.sg |
| Source: | PLoS ONE. 7/26/2024, Vol. 19 Issue 7, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0307818 |
